← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2024-03-01

Drug application

FDA Application #

ANDA218278

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Pharma Inc.

First approval

2024-03-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown